Cathie Wood Takes $16.5M Off Elon and Vlad’s Table as ARK Courts Biotech’s Next Big Thing
Cathie Wood is cutting back on two of her biggest tech bets. Her firm, ARK Invest, sold $16.5 million worth of the two stocks on Tuesday alone, continuing a recent selling spree as Wood puts more money into biotech, robotics and other emerging technologies.
And SpaceX accounted for most of Tuesday's selling.
ARK unloaded 54,873 shares of SpaceX, worth $9.43 million based on the stock's $171.92 closing price. The shares came out of its Next Generation Internet ETF (ARKW), although SpaceX remains the fund's second-largest holding at 4.51% of assets.
Meanwhile, ARK sold another 63,466 shares of Robinhood across its flagship Innovation ETF (ARKK). Those sales were worth $7.1 million based on Robinhood's $112 closing price at the time.
Neither stock has exactly set the market on fire this year. SpaceX is up just 1% in 2026, even as Elon Musk looks to turn Starlink into a serious competitor to traditional cellphone carriers.
The company recently announced a deal to acquire additional wireless spectrum, potentially giving Starlink the resources it needs to expand beyond satellite internet and compete more directly with AT&T, Verizon and T-Mobile.
Of course, building out a nationwide wireless business won't come cheap. SpaceX will need to invest heavily in satellites, network infrastructure and attracting customers before those plans can translate into meaningful profits.
Robinhood, meanwhile, has had an even tougher year, with shares down 5%.
CEO Vlad Tenev has been working to turn the brokerage into something much bigger than a stock-trading app, expanding into cryptocurrency, tokenized assets and blockchain infrastructure. But those efforts are still developing, and Robinhood remains heavily exposed to fluctuations in crypto activity and retail trading.
And Wood hasn't exactly been waiting around to see how things play out.
On Thursday, ARK reportedly sold another $21.7 million in Robinhood shares and $4.7 million in SpaceX stock. The firm has also been trimming positions in AMD, Alphabet and Shopify, making it clear that the selling extends well beyond these two companies.
So where is Wood putting that money?
For starters, ARK has been buying shares of gene-editing companies CRISPR Therapeutics, Intellia Therapeutics and Beam Therapeutics. It's also been adding to warehouse automation company Symbotic and autonomous-driving developer Kodiak AI.
In other words, Wood is still betting heavily on emerging technologies. She's just spreading more of those bets into industries outside the biggest names in tech.
So is Wood starting to see more opportunity in smaller biotech and robotics companies than in some of her longtime tech favorites?
It's hard to say. She hasn't explained the recent sales, but her trading activity shows where she's putting more money to work. And right now, that's increasingly in gene editing, automation and autonomous vehicles rather than SpaceX and Robinhood.
At the time of publishing this article, Stocks.News holds positions in Robinhood as mentioned in the article.